📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Gene modification strategies using AO-mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients. (2020)

First Author: Solberg MH
Attributed to:  FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1049/enb.2020.0017

PubMed Identifier: 36968157

Publication URI: http://europepmc.org/abstract/MED/36968157

Type: Journal Article/Review

Volume: 4

Parent Publication: Engineering biology

Issue: 3

ISSN: 2398-6182